Immunohistochemical patterns of ProEx C in vulvar squamous lesions: Detection of overexpression of MCM2 and TOP2A

American Journal of Surgical Pathology

Volumn 34, Issue 9, 2010, Pages 1250-1257

  Chen, Hui ^a   Gonzalez, Jorge L ^a   Brennick, Jeoffry B ^a   Liu, Miaoliang ^a   Yan, Shaofeng ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

condyloma; lichen sclerosus; ProEx C; squamous cell carcinoma; vulvar intraepithelial neoplasia

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II ALPHA; MCM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VULVA TUMOR;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL NUCLEUS; CELL PROLIFERATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL; VULVAR LICHEN SCLEROSUS; VULVAR NEOPLASMS;

EID: 77956228737     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181ecf829     Document Type: Article

References (32)

1. Al-Ghamdi A, Freedman D, Miller D, et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol. 2002;84:94-101.
2. Al-Saleh W, Delvenne P, Greimers R, et al. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol. 1995;104:154-160.
3. Badr RE, Walts AE, Chung F, et al. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol. 2008;32:899-906.
4. Bailis JM, Forsburg SL. MCM proteins: DNA damage, mutagenesis and repair. Curr Opin Genet Dev. 2004;14:17-21.
5. Beccati MD, Buriani C, Pedriali M, et al. Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology. Cancer. 2008;114:196-203.
6. Brustmann H, Naude S. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol. 2002; 86:192-199.
7. Conesa-Zamora P, Domenech-Peris A, Ortiz-Reina S, et al. Immunohistochemical evaluation of ProEx C in human papilloma-virus-induced lesions of the cervix. J Clin Pathol. 2009;62:159-162.
8. Crum CP, Granter SR. Squamous neoplasia of the vulva. In: Crum CP, Lee KR, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia, PA: W B Saunders Co; 2006:109-145.
9. Ghittoni R, Accardi R, Hasan U, et al. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes. 2010;40:1-13.
10. Heck MM, Hittelman WN, Earnshaw WC. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci\USA. 1988;85:1086-1090.
11. Hoevenaars BM, van der Avoort IA, de Wilde PC, et al. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer. 2008;123:2767-2773.
12. Ishimi Y, Okayasu I, Kato C, et al. Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix. Eur J Biochem. 2003;270:1089-1101.
13. Kelly D, Kincaid E, Fansler Z, et al. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer. 2006;108: 494-500.
14. Lei M. The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets. 2005;5:365-380.
15. Lynch BJ, Guinee DG Jr, Holden JA. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Hum Pathol. 1997;28:1180-1188.
16. Malinowski DP. Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease. Biotechniques. 2005;38:S17-S23.
17. Masuda T, Yabushita H, Sawaguchi K, et al. Immunohistochemical assessment of the growth fraction in cervical cancers using the monoclonal antibody Ki-67; relationship to the clinical stage, histologic type and DNA content. Asia Oceania J Obstet Gynaecol. 1992;18:81-87.
18. Modesitt SC, Groben PA, Walton LA, et al. Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors. Gynecol Oncol. 2000;76: 51-55.
19. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol. 2008;27:125-135.
20. Nascimento AF, Granter SR, Cviko A, et al. Vulvar acanthosis with altered differentiation: a precursor to verrucous carcinoma? Am J Surg Pathol. 2004;28:638-643.
21. Ordi J, Alejo M, Fuste V, et al. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Am J Surg Pathol. 2009;33: 1659-1665.
22. Pinto AP, Schlecht NF, Woo TY, et al. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol. 2008;21: 1067-1074.
23. Rolfe KJ, Eva LJ, MacLean AB, et al. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer. 2001;11:113-118.
24. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology. 2005;331:269-291.
25. Shi J, Liu H, Wilkerson M, et al. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol. 2007;38:1335-1344.
26. Shroyer KR, Homer P, Heinz D, et al. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and mini-chromosome maintenance protein 2 expression in cervical cytology. Cancer. 2006;108:324-330.
27. Siddiqui MT, Cohen C, Nassar A. Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing. Am J Clin Pathol. 2008;130:765-770.
28. Sirieix PS, O'Donovan M, Brown J, et al. Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus. Clin Cancer Res. 2003;9:2560-2566.
29. Tan DF, Huberman JA, Hyland A, et al. MCM2-a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer. 2001;1:6.
30. Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002;3:430-440.
31. Williams GH, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci\USA. 1998;95:14932-14937.
32. Yang B, Hart W. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol. 2000;24:429-441.